Literature DB >> 22154216

TNF-α induced secretion of HMGB1 from non-immune canine mammary epithelial cells (MTH53A).

Saskia Willenbrock1, Olga Braun, Judith Baumgart, Sandra Lange, Christian Junghanss, Alexander Heisterkamp, Ingo Nolte, Jörn Bullerdiek, Hugo Murua Escobar.   

Abstract

BACKGROUND: Mammary neoplasias are one of the most frequent and spontaneously occurring malignancies in dogs and humans. Due to the similar anatomy of the mammary gland in both species, the dog has become an important animal model for this cancer entity. In human breast carcinomas, the overexpression of a protein named high-mobility group box 1 (HMGB1) was reported. Cells of the immune system were described to release HMGB1 actively exerting cytokine function. Thereby it is involved in the immune system activation, tissue repair, and cell migration. Passive release of HMGB1 by necrotic cells at sites of tissue damage or in necrotic hypoxic regions of tumors induces cellular responses e.g. release of proinflammatory cytokines leading to elevated inflammatory response and neo-vascularization of necrotic tumor areas. Herein we investigated if a time-dependent stimulation with the separately applied proinflammatory cytokines TNF-α and IFN-γ can cause secretion of HMGB1 in a non-immune related HMGB1-non-secreting epithelial canine mammary cell line (MTH53A) derived from non-neoplastic tissue.
METHODS: The canine cell line was transfected with recombinant HMGB1 bicistronic expression vectors and stimulated after transfection with the respective cytokine independently for 6, 24 and 48 h. HMGB1 protein detection was performed by Western blot analysis and quantified a by enzyme-linked immunosorbent assay. Live cell laser scanning multiphoton microscopy of MTH53A cells expressing a HMGB1-GFP fusion protein was performed in order to examine, if secretion of HMGB1 under cytokine stimulating conditions is also visible by fluorescence imaging.
RESULTS: The observed HMGB1 release kinetics showed a clearly time-dependent manner with a peak release 24h after TNF-α stimulation, while stimulation with IFN-γ had only small effects on the HMGB1 release. Multiphoton HMGB1 live cell microscopy showed diffuse cell membrane structure changes 29 h after cytokine-stimulation but no clear secretion of HMGB1-GFP after TNF-α stimulation was visible.
CONCLUSION: Our results demonstrate that non-immune HMGB1-non-secreting cells of epithelial origin derived from mammary non-neoplastic tissue can be induced to release HMGB1 by single cytokine application. This indicates that tumor and surrounding tissue can be stimulated by tumor present inflammatory and necrotic cytokines to release HMGB1 acting as neo-vascularizing factor thus promoting tumor growth.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22154216     DOI: 10.1016/j.cyto.2011.11.011

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  10 in total

1.  Anti-HMGB1 Neutralizing Antibody Attenuates Periodontal Inflammation and Bone Resorption in a Murine Periodontitis Model.

Authors:  Chiaki Yoshihara-Hirata; Keisuke Yamashiro; Tadashi Yamamoto; Hiroaki Aoyagi; Hidetaka Ideguchi; Mari Kawamura; Risa Suzuki; Mitsuaki Ono; Hidenori Wake; Masahiro Nishibori; Shogo Takashiba
Journal:  Infect Immun       Date:  2018-04-23       Impact factor: 3.441

2.  The effect of calcitriol on high mobility group box 1 expression in periodontal ligament cells during orthodontic tooth movement in rats.

Authors:  Jian Cui; Juan Li; Wei Wang; Xiuchun Han; Juan Du; Jing Sun; Wei Feng; Bo Liu; Hongrui Liu; Norio Amizuka; Minqi Li
Journal:  J Mol Histol       Date:  2016-03-08       Impact factor: 2.611

Review 3.  Novel insights for high mobility group box 1 protein-mediated cellular immune response in sepsis: A systemic review.

Authors:  Li-Feng Huang; Yong-Ming Yao; Zhi-Yong Sheng
Journal:  World J Emerg Med       Date:  2012

4.  Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells.

Authors:  Kamolporn Amornsupak; Tonkla Insawang; Peti Thuwajit; Pornchai O-Charoenrat; Suzanne A Eccles; Chanitra Thuwajit
Journal:  BMC Cancer       Date:  2014-12-15       Impact factor: 4.430

5.  Vitamin D reduces inflammatory response in asthmatic mice through HMGB1/TLR4/NF‑κB signaling pathway.

Authors:  Han Zhang; Nan Yang; Tianyue Wang; Bing Dai; Yunxiao Shang
Journal:  Mol Med Rep       Date:  2017-12-07       Impact factor: 2.952

6.  Peroxiredoxin-mediated disulfide bond formation is required for nucleocytoplasmic translocation and secretion of HMGB1 in response to inflammatory stimuli.

Authors:  Man Sup Kwak; Hee Sue Kim; Khulan Lkhamsuren; Young Hun Kim; Myeong Gil Han; Jae Min Shin; In Ho Park; Woo Joong Rhee; Se Kyoung Lee; Sue Goo Rhee; Jeon-Soo Shin
Journal:  Redox Biol       Date:  2019-04-15       Impact factor: 11.799

Review 7.  Chronic cerebral aspects of long COVID, post-stroke syndromes and similar states share their pathogenesis and perispinal etanercept treatment logic.

Authors:  Ian Albert Clark
Journal:  Pharmacol Res Perspect       Date:  2022-04

8.  Mathematical Model of Innate and Adaptive Immunity of Sepsis: A Modeling and Simulation Study of Infectious Disease.

Authors:  Zhenzhen Shi; Chih-Hang J Wu; David Ben-Arieh; Steven Q Simpson
Journal:  Biomed Res Int       Date:  2015-09-08       Impact factor: 3.411

9.  The proinflammatory cytokine high-mobility group box-1 mediates retinal neuropathy induced by diabetes.

Authors:  Ahmed M Abu El-Asrar; Mohammad Mairaj Siddiquei; Mohd Imtiaz Nawaz; Karel Geboes; Ghulam Mohammad
Journal:  Mediators Inflamm       Date:  2014-03-10       Impact factor: 4.711

10.  2-O, 3-O desulfated heparin (ODSH) increases bacterial clearance and attenuates lung injury in cystic fibrosis by restoring HMGB1-compromised macrophage function.

Authors:  Mao Wang; Alex G Gauthier; Thomas P Kennedy; Haichao Wang; Uday Kiran Velagapudi; Tanaji T Talele; Mosi Lin; Jiaqi Wu; LeeAnne Daley; Xiaojing Yang; Vivek Patel; Sung Soo Mun; Charles R Ashby; Lin L Mantell
Journal:  Mol Med       Date:  2021-07-16       Impact factor: 6.354

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.